Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

A guided path back to work after blood cancer: a trial tests the impact

NCT ID NCT06262789

Symptom relief Sponsor: University Hospital, Angers Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 10, 2026 · Last updated Sep 04, 2026 · Updated 2 times

Summary

This trial tests whether a dedicated 'return-to-work after cancer' consultation can help people who have been treated for blood cancers like leukemia, lymphoma, or multiple myeloma get back to their jobs. The consultation, led by an occupational health specialist with possible support from a psychologist, nurse, or social worker, aims to identify obstacles and guide patients through the return-to-work process. The study includes adults aged 18 to 55 who have completed their main chemotherapy and have not yet returned to work. The main goal is to see if this early support increases the percentage of patients who return to work within a year, potentially improving their quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A specialized 'return-to-work after cancer' consultation led by an occupational health specialist, with possible support from a psychologist, nurse, or social worker.
What this could lead to
If effective, this consultation could become a standard support service to help blood cancer survivors successfully return to work, improving their financial stability, social connections, and self-esteem.
What could go wrong
This is a relatively small, early-stage trial, and the benefit of the consultation may be limited by individual circumstances, workplace factors, or the severity of the cancer and its treatment. The outcome depends on many personal and occupational variables.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 264 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 55 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria : * Patient with hematological malignancy controlled after treatment * Induction/consolidation chemotherapy completed (excluding maintenance therapy) * Patient aged 18 to 55 * Patient having worked at least 6 months in the 2 years before diagnosis of hematological malignancy * Patient who has not yet returned to work since diagnosis of hematological malignancy * Signed informed consent form Exclusion Criteria: * Patient choosing not to return to work * Patient not affiliated to a social security system * Patient with legal guardian or legal trustee * Patient not understanding French * Patient with severe cognitive impairment at diagnosis, incompatible with the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hematological malignancy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hematopoietic and lymphoid system neoplasm leukemia lymphoma plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Leukemia Lymphoma Multiple myeloma

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    10 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Angers University hospital

    RECRUITING

    Angers, France

  • Brest University Hospital, Morvan Site

    RECRUITING

    Brest, France

  • Caen University hospital

    NOT_YET_RECRUITING

    Caen, France

  • Centre Henri Becquerel

    RECRUITING

    Rouen, France

  • Le Havre Hospital Group

    NOT_YET_RECRUITING

    Montivilliers, France

  • Pays de Morlaix Hospital

    NOT_YET_RECRUITING

    Morlaix, France

  • Rennes University Hospital, Pontchaillou site

    NOT_YET_RECRUITING

    Rennes, France

  • Rouen University Hospital

    NOT_YET_RECRUITING

    Rouen, France

  • Service Hématologie, Cholet Hospital

    NOT_YET_RECRUITING

    Cholet, France

  • Tours University Hospital, Bretonneau Site

    RECRUITING

    Tours, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.